A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids
- PMID: 34978092
- DOI: 10.1002/bmc.5308
A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids
Abstract
Kynurenine (KYN) is synthesized from an essential amino acid, tryptophan, by tryptophan 2,3-dioxygenase or indoleamine 2,3-dioxygenase via N-formyl-KYN in vivo. Subsequently, KYN acts as a precursor of some neuroactive metabolites such as kynurenic acid, quinolinic acid, and an important enzyme co-factor, nicotine adenine dinucleotide. These metabolites of tryptophan are a part of the 'kynurenine pathway.' In addition, KYN functions as an endogenous ligand for the aryl hydrocarbon receptor, which acts as a transcription factor. The levels of tryptophan metabolites are important for the assessment of the stage of neurological disorders, and therefore have garnered significant interest for clinical diagnosis. In this review, the detection of kynurenine, kynurenic acid, quinolinic acid, and other tryptophan metabolites performed via chromatographic methods such as HPLC using UV absorbance, fluorescence, and chromatographic-mass spectrometric detection is summarized.
Keywords: kynurenic acid; kynurenine; kynurenine pathway; quinolinic acid; tryptophan.
© 2022 John Wiley & Sons, Ltd.
Similar articles
-
A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.Brain. 1993 Dec;116 ( Pt 6):1425-50. doi: 10.1093/brain/116.6.1425. Brain. 1993. PMID: 8293279
-
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.Neuroscience. 1992 Nov;51(1):25-39. doi: 10.1016/0306-4522(92)90467-g. Neuroscience. 1992. PMID: 1465184
-
Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.Brain. 1992 Oct;115 ( Pt 5):1249-73. doi: 10.1093/brain/115.5.1249. Brain. 1992. PMID: 1422788
-
[Kynurenine and its metabolites in nervous system diseases].Orv Hetil. 1992 Jul 19;133(29):1803-7. Orv Hetil. 1992. PMID: 1386152 Review. Hungarian.
-
The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.J Affect Disord. 2023 Oct 15;339:624-632. doi: 10.1016/j.jad.2023.07.078. Epub 2023 Jul 17. J Affect Disord. 2023. PMID: 37467793
Cited by
-
To elucidate the mechanism of "Scrophulariae Radix-Fritillaria" in goiter by integrated metabolomics and serum pharmaco-chemistry.Front Pharmacol. 2024 May 17;15:1206718. doi: 10.3389/fphar.2024.1206718. eCollection 2024. Front Pharmacol. 2024. PMID: 38828449 Free PMC article.
-
Research progress on the kynurenine pathway in the prevention and treatment of Parkinson's disease.J Enzyme Inhib Med Chem. 2023 Dec;38(1):2225800. doi: 10.1080/14756366.2023.2225800. J Enzyme Inhib Med Chem. 2023. PMID: 37381707 Free PMC article. Review.
-
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design.Pharmaceuticals (Basel). 2025 Apr 22;18(5):607. doi: 10.3390/ph18050607. Pharmaceuticals (Basel). 2025. PMID: 40430428 Free PMC article. Review.
-
Maternal separation leads to dynamic changes of visceral hypersensitivity and fecal metabolomics from childhood to adulthood.Sci Rep. 2023 May 11;13(1):7670. doi: 10.1038/s41598-023-34792-7. Sci Rep. 2023. PMID: 37169847 Free PMC article.
-
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.Int J Mol Sci. 2024 Aug 21;25(16):9082. doi: 10.3390/ijms25169082. Int J Mol Sci. 2024. PMID: 39201768 Free PMC article. Review.
References
REFERENCES
-
- Abuin-Martinez, C., Vidal, R., Gutierrez-Lopez, M. D., Perez-Hernandez, M., Gimenez-Gomez, P., Morales-Puerto, N., O'Shea, E., & Colado, M. I. (2021). Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor. Neuropharmacology, 187. https://doi.org/10.1016/j.neuropharm.2021.108490
-
- Adriaens, P., Meesschaert, B., Wuyts, W., Vaderhaeghe, H., & Eyssen, H. (1977). Separation of ninhydrin-positive compounds on a single-column amino-acid analyzer using lithium buffers. Journal of Chromatography, 140, 103-108. https://doi.org/10.1016/s0021-9673(00)83608-0
-
- Al-Karagholi, M. A-M., Hansen, J. M., Abou-Kassem, D., Hansted, A. K., Ubhayasekera, K., Bergquist, J., Vecsei, L., Jansen-Olesen, I., & Ashina, M. (2021). Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers. Pharmacology Research & Perspectives, 9(2). https://doi.org/10.1002/prp2.741
-
- Atsumi, M., Mawatari, K., Morooka, A., Yasuda, M., Fukuuchi, T., Yamaoka, N., Kaneko, K., Nakagomi, K., & Oku, N. (2019). Simultaneous determination of kynurenine and kynurenic acid by high-performance liquid chromatography photoirradiation system using a mobile phase containing 18-crown-6. International Journal of Tryptophan Research, 12, 117864691983455. https://doi.org/10.1177/1178646919834551
-
- Boulet, L., Faure, P., Flore, P., Monteremal, J., & Ducros, V. (2017). Simultaneous determination of tryptophan and 8 metabolites in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 1054, 36-43. https://doi.org/10.1016/j.jchromb.2017.04.010
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources